NASDAQ
Federated Hermes Inc. raised its holdings in shares of 10x Genomics (NASDAQ: TXG) by 665.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and...
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region PLEASANTON, Calif. and SYDNEY , Nov. 18, 2025 /PRNewswir...
PLEASANTON, Calif. , Nov. 11, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i...
10x Genomics, Inc. ( TXG ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Cassie Corneau - Manager of Investor Relations & Strategic Finance Serge Saxonov - Co-Founder, CEO & ...
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics c...
10x Genomics (TXG) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago....
PLEASANTON, Calif. , Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September ...
Torex Gold Resources Inc. ( TXG:CA ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Dan Rollins - Senior Vice President of Corporate Development & Investor Relations Jody Kuze...
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
10x Genomics (NASDAQ: TXG - Get Free Report) will likely be announcing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.27...
No price data available for this timeframe.